Atento S.A. (ATTO)
$20.43
vs last close−0.87 (−4.08%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Insiders | 16.43% | 7.50M shares | |
|---|---|---|---|
| 6 holders · as of Aug 7, 2026 | |||
| Strategic holders | 32.87% | 15.01M shares | |
| 6 holders · as of Aug 13, 2026 | |||
| Other | 50.70% | 23.14M shares | |
| remainder | |||
45.65M company shares as of Sep 22, 2026 · holders as of their latest filing
13F
No 13F holders on record.
13D/G · 5% or more, as filed
No 13D/G filer at 5% or more on record.
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Aug 5, 2026 | Goldman Sachs Group Incother: Former 10% Owner | Purchase · 7 lots | 190,807 | $21.00 | 190,807 |
| Aug 5, 2026 | Colin Walshdirector | Purchase · 7 lots | 190,807 | $21.00 | 190,807 |
| Aug 6, 2026 | Colin Walshdirector | Purchase | 500,000 | $17.00 | 3,020,632 |
| Aug 5, 2026 | Colin Walshdirector | Sale · 22 lots | 105,607 | $21.28 | 0 |
| Aug 6, 2026 | Goldman Sachs Group Incother: Former 10% Owner | Purchase | 500,000 | $17.00 | 3,020,632 |
| Aug 5, 2026 | Goldman Sachs Group Incother: Former 10% Owner | Sale · 22 lots | 105,607 | $21.28 | 0 |
| Aug 6, 2026 | venBio Global Strategic Fund IV, L.P.10 percent owner | Purchase | 382,352 | $17.00 | 4,181,367 |
| Aug 6, 2026 | Redmile Group, LLC10 percent owner | Purchase · 2 lots | 600,000 | $17.00 | 2,165,708 |
| Aug 6, 2026 | Sanofi10 percent owner | Purchase | 300,000 | $17.00 | 1,082,855 |
| Aug 6, 2026 | Life Sciences XI L.P. Frazier10 percent owner | Purchase | 588,235 | $17.00 | 6,154,213 |
House and Senate disclosures
Not reported.